Gold Conjugation Kit (20 nm, 20 OD)
Be the first to review this product! Submit a review
|
(12 Publications)
- Rapid Conjugation: achieve Gold 20 nm, 20 OD nanoparticle labeling in under 1 hour with less than 5 minutes of hands-on time.
- High Efficiency: ensures 100% antibody recovery, meaning no loss of valuable antibodies.
- Versatility: suitable for conjugating antibodies making it suitable for various applications e.g. Lateral flow assays (LFA).
- Conjugation
Supplier Data
Conjugation - Gold Conjugation Kit (20 nm, 20 OD) (AB188215)
- LFA
PubMed
Lateral flow assay - Gold Conjugation Kit (20 nm, 20 OD) (AB188215)
Gwyn, Sarah, et al used Gold Conjugation Kit (20 nm, 20 OD) (ab188215) as part of examining the detection of antibodies against immunodominant antigen Pgp3 from Chlamydia trachomatis. They used the kit to conjugate Gold to Pgp3 protein for use in lateral flow assay.
LFA test. Shown are results of the LFA run with positive (left) and negative (right) control sera.
Image from Gwyn et al., J Immunol Methods, 435:27-31; doi: 10.1016/j.jim.2016.05.008. Reproduced under the Creative Commons license https://creativecommons.org/licenses/by/4.0/
Product details
Gold Conjugation Kit (20 nm, 20 OD)(ab188215) allows antibodies or proteins to be covalently attached to ultra-stable 20 nm Gold nanoparticles at very high OD quickly and easily. The nanoparticles in the Abcam's Gold Conjugation Kit have a protective surface coat that can withstand the most extreme conditions (e.g. 2.5M NaOH at 70°C for > 1 hour). The hands-on time for the Abcam Gold conjugation procedure is around 2 minutes and the conjugate is ready to use within 20 minutes. The researcher simply pipettes the biomolecule into a vial containing the nanoparticles of the Gold Conjugation Kit.
The nanoparticles in this kit are supplied as a freeze-dried mixture. The conjugation reaction is initiated simply by reconstituting the freeze-dried nanoparticles with the antibody, which becomes attached (through lysine residues) to the surface of the nanoparticles.
The resulting covalent conjugates are more stable than those prepared by passive adsorption methods. Moreover, unlike passive methods, the coating process is independent of the isoelectric point of the antibody, avoiding the need for extensive trials at different pH values. All antibodies can be labelled at a single pH.
The 3 and 10 Test Conjugation Kits are designed to label 12 µl of antibody per vial. The 1 Test Conjugation Kit is designed to label 120 µl of antibody per vial.
Benefits
Easy and rapid conjugation - only 2 minutes hands-on time and 100% recovery of materials
Site-specific labelling - Antigen binding sites of antibodies are free to bind the target molecule
Proprietary surface coating prevents metal-protein interactions, and enables covalent attachment to the Gold - Stable conjugates formed
Fully scalable - Easy transfer from R&D to manufacturing
Uniform spherical shape and narrow size distribution - Consistent high quality and excellent batch-to-batch reproducibility
Buffer requirements:
The biomolecule to be conjugated should ideally be in 10 mM amine-free buffer (e.g. MES, MOPS, HEPES), pH range 6.5-8.5. Sugars have no effect on conjugation efficiency. For incompatible buffers and low antibody concentrations, use our rapid antibody purification and concentration kits for Nanoparticles. To learn more about incompatible buffers, please refer to the protocol booklet.
Other Products
Learn about our Lightning-Link® antibody labeling kits and their advantages here.
This product is manufactured by Expedeon, an Abcam company, and was previously called 20nm InnovaCoat® GOLD. 229-0015 is the same as the 1 x 25 µg size. 229-0010 is the same as the 10 x 2.5 µg size. 229-0005 is the same as the 3 x 2.5 µg size.
What's included?
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
- Download websiteProtocolBooklet|en
Target data
Publications (12)
Recent publications for all applications. Explore the full list and refine your search
GeroScience 47:3709-3723 PubMed39656404
2024
Applications
Unspecified application
Species
Unspecified reactive species
PLoS neglected tropical diseases 18:e0012294 PubMed38950072
2024
Applications
Unspecified application
Species
Unspecified reactive species
PLoS biology 19:e3001166 PubMed33826607
2021
Applications
Unspecified application
Species
Unspecified reactive species
ACS sensors 4:3072-3079 PubMed31713421
2019
Applications
Unspecified application
Species
Unspecified reactive species
ACS chemical neuroscience 10:3404-3408 PubMed31274276
2019
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 27:3725-3732.e5 PubMed31242406
2019
Applications
Unspecified application
Species
Unspecified reactive species
Analytical chemistry 89:6608-6615 PubMed28499086
2017
Applications
Unspecified application
Species
Unspecified reactive species
Histochemistry and cell biology 148:3-12 PubMed28283744
2017
Applications
Unspecified application
Species
Unspecified reactive species
Journal of immunological methods 435:27-31 PubMed27208400
2016
Applications
Unspecified application
Species
Unspecified reactive species
Nature protocols 11:617-33 PubMed26938114
2016
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com